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Abstract 
Introduction: The gastrointestinal stromal tumors (GIST) are mesenchymal tumors, most commonly affecting the 
stomach and small bowel. Only few cases of port-site recurrence after laparoscopic treatment have been reported. 
We herein report the case of a parietal recurrence on the extraction incision site, 7 years after laparoscopic surgery for 
small bowel GIST.
Case report: A 47 years-old female patient was hospitalized in November 2007 for isolated pelvic pain. CT scan 
showed an intestinal tumor with a benign aspect measuring 50 mm. A laparoscopy-assisted resection was performed. 
Surgical exploration found a 7 cm small bowel tumor. It was extracted through a supra-pubic transversal incision 
without a wound protector and then resected. Histologic analysis revealed an intestinal GIST with high aggressive 
potential (five mitosis per field), with CD117 positive at the immunohistochemical examination. The patient had 
no adjuvant chemotherapy. Seven years later, the patient was readmitted for an abdominal mass at the site of the 
supra-pubic scar. Abdomino-pelvic CT scan showed a 10 × 7.5 cm solid mass of the abdominal wall. Percutaneous 
biopsies were done and the pathological analysis revealed a mesenchymal-cell tumor, positive to CD117 and DOG1 at 
the immunohistochemical examination. Final diagnosis was abdominal wall recurrence of GIST secondary to tumor-
contamination during the first surgery.
Conclusion: Abdominal wall recurrence of GIST after laparoscopic surgery is rarely reported. This complication 
should be avoided with preventive measures such as the use of extraction bags or wound protectors.
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Introduction
Gastrointestinal stromal tumors are rare tumors second-
ary to a malignant proliferation of mesenchymal cells. 
They affect more frequently the stomach and the small 
bowel in comparison with other segments of the digestive 
tract (Landi et al. 2015).
Enbloc surgical resection (R0) with a safety margin of 
1–2  cm is actually the only potentially curative treat-
ment. Imatinib based adjuvant chemotherapy is comple-
mentary to the surgery to improve the survival and the 
disease free survival. Laparoscopy has been used suc-
cessfully in the treatment of digestive GIST with minor 
complications. Particularly, very few cases of port sites 
recurrences have been reported (Furukawa et al. 2012).
We herein report the case of an abdominal wall recur-
rence on the site of the extraction incision of a laparo-
scopically resected small bowel stromal tumor.
Case report
We report the case of a 47 years-old female patient, who 
was referred to our unit in November 2007 for isolated 
pelvic pain. Clinical examination was without abnor-
malities. The abdominal pelvic ultrasound revealed a 
60 mm hypoechoic and heterogeneous mass in the right 
iliac fossa. The abdominal pelvic computed tomography 
showed a tumor measuring 50 × 50 × 48 mm, attached 
to the anterior wall of the cecum and the right colon 
(Fig. 1).
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The multidisciplinary meeting decided to perform 
a diagnostic and therapeutic laparoscopy. The laparo-
scopic exploration showed a 70 mm tumor of the small 
bowel, 70  cm upstream the last ileal loop. The tumor 
was extracted through a small suprapubic incision, 
without the use of a wound protector. It was resected 
with a safety margin of 2  cm and an end-to-end anas-
tomosis was performed. The postoperative course was 
marked by an infection of the extraction’s site. The 
pathology specimen findings revealed a stromal tumor 
with a high aggressive potential (five mitosis per field), 
positive to CD117 at the immunohistochemical exami-
nation. An Imatinib adjuvant therapy was indicated, 
but the patient did not receive it because of financial 
considerations.
The patient had a postoperative follow-up (clinical 
examination, abdominal ultrasonography and abdominal 
computed tomography alternately) every 3 months dur-
ing the first year, then every 6 months during the second 
and the third year. After that, the patient stopped her fol-
low-up on her own.
Seven years after the surgical resection, the patient 
was hospitalized for a pelvic mass underneath the old 
scar. The abdominal examination found a mass measur-
ing 60/70 mm. The abdominal pelvic CT scan showed a 
100/75 mm solid mass of the abdominal wall alongside to 
the pubic symphysis (Fig. 2).
Percutaneous biopsies of the tumor were made and 
histologic examination showed an aspect of low-grade 
malignancy GIST. An enbloc surgical resection of the 
tumor was performed, with a safety margin of 1 cm. The 
wall defect measured 6 cm in diameter and it was closed 
by direct suture. The pathological examination revealed a 
tumoral proliferation of spindle atypical cells with mitotic 
signs. The immunehistochemical examination showed an 
important positivity to CD117 and DOG1. The patient 
received adjuvant chemotherapy (Imatinib).
Discussion
We herein report the case of parietal recurrence on the 
extraction site of a GIST, after a laparoscopy-assisted 
resection. This is a rare event and only few cases have 
been reported in the literature, mainly port-site metasta-
sis (Kaczmarek et al. 2001; Davies et al. 2008; Furukawa 
et al. 2012) (Table 1).
Several mechanisms may be responsible of GIST pari-
etal recurrences (on the port sites of the extraction inci-
sions) (Martinez et al. 1995; Schaeff et al. 1998) including: 
the high pressure of CO2 insufflation; the excessive 
manipulation of the tumor during surgery (stromal 
tumors are easily friable because of their necrotic char-
acter) (Landi et  al. 2015), and secondary dissemination 
because of lack of protection of the abdominal wall dur-
ing specimen extraction.
This complication is preventable with simple measures 
such as: the extraction of the specimen in a wound pro-
tector, careful manipulation of the tumor to avoid break-
ing; peritoneal washing with cytocidal or anti-adhesive 
solution (Kaczmarek et  al. 2001; Shoup et  al. 2002; 
Davies et  al. 2008; Furukawa et  al. 2012) and even the 
resection of the port sites. The use of the wound protec-
tor aims to protect the wound edges from contamination 
(infectious or tumoral). A meta-analysis of randomized 
controlled trials evaluating the use of wound protec-
tors in gastrointestinal and biliary surgical procedures 
and the impact on surgical site infections (SSIs) showed 
nearly 50 % decrease in SSIs (RR = 0.55; 95 % CI, 0.31–
0.98; p = 0.04) just by using a wound protector (Edwards 
et al. 2012). In our case, not using a wound protector was 
responsible of a SSI immediately after the surgery and 
a tumor contamination responsible of a parietal recur-
rence 7 years later.
The influence of the surgeon was also suggested respon-
sible of 0–21 % of port-site recurrences after a laparoscopy 
Fig. 1 Computed tomography showing the intestinal tumor Fig. 2 Computed tomography showing the abdominal wall recur-
rence
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performed for cancer. An experimental study on a porcine 
model showed a tumor recurrence in 63.8 % in the con-
trol group versus 13.8 % in the protective measures group 
(Schneider et  al. 2001) suggesting that the use of stand-
ardized protective measures might reduce greatly the 
incidence of port-site recurrence (Franklin et  al. 1996). 
The protective measure in this study were: prevention of 
gas leaks, fixation of trocars, protection of the extraction 
port, rinsing of instruments with cytotoxic substances 
such as povidone iodine or hydrogen peroxyde, and clo-
sure of peritoneal wounds (Wang et al. 1999).
Although our patient had a primary resectable local-
ized GIST, a complete resection with negative micro-
scopic margins do not prevent recurrences. The 
estimation of recurrence and death risks related to the 
GIST is based on the tumor size, mitotic rate and the 
site of the tumor. This estimation allows the selection of 
patients for adjuvant Imatinib and identifying their prog-
nosis (Fletcher et  al. 2002; Miettinen and Lasota 2006; 
Dematteo et al. 2008) (Tables 2, 3). Our patient had ini-
tially a 70 mm tumor, located in the small bowel, with five 
mitosis per field, positive to CD117 and no protection 
measures during the extraction procedure. So it would be 
reasonable to label her into a “high risk” category, even 
though she had an intermediate risk of recurrence (24 %) 
according to the stratification models (Fletcher et  al. 
2002; Miettinen and Lasota 2006). A study comparing 3 
vs 1 year of Imatinib (400 mg/day) in the high-risk GIST 
patients showed that the recurrence-free survival was 
86.6  % in 3-years arm versus 60.1  % in the 1-year arm. 
Five-years overall survival was also significantly better 
in the 3-years Imatinib arm versus the 1-year arm (92 
vs. 81.7  %, p =  0.019) (George et  al. 2009). Our patient 
did not receive Imatinib after the first surgery. Adjuvant 
chemotherapy would have reduced the risk of recurrence 
(Wang et al. 1999).
Table 1 Summary of previously reported cases of GIST parietal recurrence in the literature (Kaczmarek et al. 2001; Davies 
et al. 2008; Furukawa et al. 2012)






Stomach GIST 4 × 4 cm Endoscopic wedge 
resection
Port-site metastasis >5 No information
Davies et al. 
(2008)
Stomach GIST 13 cm Laparoscopic diagnos-
tic + biopsies












Table 2 Estimation of  the recurrence risk or death linked 
to the disease in localized and resecable GISTs depending 
on tumor size and the mitotic index (Fletcher et al. 2002)
a Per 50 fields
Risk Maximum diameter Mitotic indexa
Very low risk <2 cm <5
Low risk 2–5 cm <5










Table 3 Estimation of  the recurrence risk or death linked to  the disease in  localized and  resecable GISTs depending 
on tumor size, the tumor localization and the mitotic index (Miettinen and Lasota 2006)
a Insufficient number of patients to estimate
b Per 50 Fields
Tumor’s maximum diameter (cm) Mitotic indexb Stomach GIST (%) Small bowel GIST (%) Duodenal GIST (%) Rectal GIST (%)
≤2 ≤5 0 0 0 0
>2 ≤ 5 ≤5 1.9 4.3 8.3 8.5
>5 ≤ 10 ≤5 3.6 24 –a –a
>10 ≤5 12 52 34 57
≤2 >5 0 50 –a 54
>2 ≤ 5 >5 16 73 50 52
>5 ≤ 10 >5 55 85 –a –a
>10 >5 86 90 86 71
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Conclusion
Parietal recurrence of GIST after laparoscopy is rarely 
reported. They are considered as metastasis. This compli-
cation could be avoided with preventive measures such 
as the use of extraction bags or wound protectors.
Consent
The patient gave signed statement, which authorises the 
use of her personal and/or medical information in the 
publication of this study.
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